These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2. Jamous YF; Alhomoud DA Cureus; 2023 Sep; 15(9):e45602. PubMed ID: 37868494 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2: Unique Challenges of the Virus and Vaccines. Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900 [TBL] [Abstract][Full Text] [Related]
10. Implication of in silico studies in the search for novel inhibitors against SARS-CoV-2. Ali F; Alom S; Shakya A; Ghosh SK; Singh UP; Bhat HR Arch Pharm (Weinheim); 2022 May; 355(5):e2100360. PubMed ID: 35244237 [TBL] [Abstract][Full Text] [Related]
11. Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination. Abdul-Wahab Kadhum A; Rushdi Abdullah A; Mujahid A Arch Razi Inst; 2023 Jun; 78(3):1071-1075. PubMed ID: 38028836 [TBL] [Abstract][Full Text] [Related]
12. A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®. Speich B; Chammartin F; Smith D; Stoeckle MP; Amico P; Eichenberger AL; Hasse B; Schuurmans MM; Müller T; Tamm M; Dickenmann M; Abela IA; Trkola A; Hirsch HH; Manuel O; Cavassini M; Hemkens LG; Briel M; Mueller NJ; Rauch A; Günthard HF; Koller MT; Bucher HC; Kusejko K; Trials; 2021 Oct; 22(1):724. PubMed ID: 34674742 [TBL] [Abstract][Full Text] [Related]
13. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study. Aldali J; Meo SA; Al-Khlaiwi T Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109 [TBL] [Abstract][Full Text] [Related]
14. Developmental Status of the Potential Vaccines for the Mitigation of the COVID-19 Pandemic and a Focus on the Effectiveness of the Pfizer-BioNTech and Moderna mRNA Vaccines. Noor R Curr Clin Microbiol Rep; 2021; 8(3):178-185. PubMed ID: 33686365 [TBL] [Abstract][Full Text] [Related]
15. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection. Costanzo M; De Giglio MAR; Roviello GN Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson. Patel R; Kaki M; Potluri VS; Kahar P; Khanna D Hum Vaccin Immunother; 2022 Dec; 18(1):2002083. PubMed ID: 35130825 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021. Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519 [TBL] [Abstract][Full Text] [Related]
18. Covid-19, an unfinished story. Buisson Y Presse Med; 2022 Sep; 51(3):104131. PubMed ID: 35667598 [TBL] [Abstract][Full Text] [Related]
19. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
20. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]